These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7671609)

  • 1. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics.
    Everett SL; Kowalski RP; Karenchak LM; Landsittel D; Day R; Gordon YJ
    Cornea; 1995 Jul; 14(4):382-7. PubMed ID: 7671609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.
    Shulman DG; Sargent JB; Stewart RH; Mester U
    Eur J Ophthalmol; 1996; 6(4):361-7. PubMed ID: 8997575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial isolates and their antimicrobial susceptibility pattern among patients with external ocular infections at Borumeda hospital, Northeast Ethiopia.
    Shiferaw B; Gelaw B; Assefa A; Assefa Y; Addis Z
    BMC Ophthalmol; 2015 Aug; 15():103. PubMed ID: 26268424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activities of topical antibiotics against conjunctival isolates.
    Iqbal J; Rahman M; Kabir MS; Sharif AJ
    J Antimicrob Chemother; 1999 Apr; 43(4):611-2. PubMed ID: 10350400
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro antibiotic susceptibilities of ocular isolates in North and South America. In Vitro Antibiotic Testing Group.
    Jensen HG; Felix C
    Cornea; 1998 Jan; 17(1):79-87. PubMed ID: 9436885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics.
    Kaliamurthy J; Nelson Jesudasan CA; Geraldine P; Parmar P; Kalavathy CM; Thomas PA
    Ophthalmic Res; 2005; 37(3):117-22. PubMed ID: 15746568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin ophthalmic solution in the treatment of conjunctivitis and blepharitis: a comparison with fusidic acid.
    Adenis JP; Colin J; Verin P; Riss I; Saint-Blancat P
    Eur J Ophthalmol; 1996; 6(4):368-74. PubMed ID: 8997576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibiotic susceptibility to fluoroquinolones].
    Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
    Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibilities to topical antibiotics of bacteria isolated from the surface of clinically symptomatic eyes.
    Egger SF; Ruckhofer J; Alzner E; Hell M; Hitzl W; Huber-Spitzy V; Grabner G
    Ophthalmic Res; 2001; 33(2):117-20. PubMed ID: 11244359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis.
    Adenis JP; Colin J; Verin P; Saint-Blancat P; Malet F
    Eur J Ophthalmol; 1995; 5(2):82-7. PubMed ID: 7549447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External ocular surface bacterial isolates and their antimicrobial susceptibility patterns among pre-operative cataract patients at Mulago National Hospital in Kampala, Uganda.
    Mshangila B; Paddy M; Kajumbula H; Ateenyi-Agaba C; Kahwa B; Seni J
    BMC Ophthalmol; 2013 Nov; 13():71. PubMed ID: 24238071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute bacterial conjunctivitis - antibiotic susceptibility and resistance to commercially available topical antibiotics in Nepal.
    Shrestha SP; Khadka J; Pokhrel AK; Sathian B
    Nepal J Ophthalmol; 2016 Jan; 8(15):23-35. PubMed ID: 28242882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.
    Jacobson JA; Call NB; Kasworm EM; Dirks MS; Turner RB
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1820-4. PubMed ID: 3072923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolones in the treatment of bacterial keratitis.
    Bower KS; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial spectrum and antimicrobial susceptibility patterns in acquired and connatal lacrimal duct stenosis.
    Prokosch V; Prokosch JE; Promesberger J; Idelevich EA; Böhm MR; Thanos S; Stupp T
    Curr Eye Res; 2014 Nov; 39(11):1069-75. PubMed ID: 24912091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and antibiotic susceptibility of bacteria isolated in patients affected with blepharitis in a tertiary eye centre in Spain.
    de Paula A; Oliva G; Barraquer RI; de la Paz MF
    Eur J Ophthalmol; 2020 Sep; 30(5):991-997. PubMed ID: 31232091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility to different topical ophthalmic antibiotics of bacterial isolates from patients with conjunctivitis.
    Giardini F; Grandi G; De Sanctis U; Eandi C; Machetta F; Pollino C; Grignolo FM
    Ocul Immunol Inflamm; 2011 Dec; 19(6):419-21. PubMed ID: 22106909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
    Friedlaender MH
    CLAO J; 1998 Jan; 24(1):48-51. PubMed ID: 9474454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis.
    Bloom PA; Leeming JP; Power W; Laidlaw DA; Collum LM; Easty DL
    Eur J Ophthalmol; 1994; 4(1):6-12. PubMed ID: 8019124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
    Goldstein MH; Kowalski RP; Gordon YJ
    Ophthalmology; 1999 Jul; 106(7):1313-8. PubMed ID: 10406613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.